Literature DB >> 9023422

Ly1- (CD5-) B cells produce interleukin (IL)-10.

R S Gieni1, D T Umetsu, R H DeKruyff.   

Abstract

Interleukin (IL)-10 enhances humoral immunity by inhibiting macrophage activation and promoting the development of Th2 cytokine synthesis. In this study we investigated the ability of conventional Ly-1- (CD5-) B cells to produce IL-10 protein. Highly purified normal, naive splenic B cells from both BALB/c and C57BL/6 mice produced IL-10 in response to stimulation with the mitogen LPS. In addition, B cells from antigen primed mice also produced IL-10 upon antigen restimulation in vitro, as analyzed by ELISA and by bioassay. Removal of Ly-1+ B cells did not appreciably reduce IL-10 production, indicating that conventional Ly-1- B cells produced IL-10. These results indicate that normal Ly-1- B cells produce significant quantities of IL-10 during mitogen- or antigen-driven immune responses. The production of IL-10 by conventional B cells may enhance their capacity to promote humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9023422     DOI: 10.1006/cimm.1996.1060

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).

Authors:  T J D'Orazio; J Y Niederkorn
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

2.  A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Authors:  Juan Manuel Spera; Juan Esteban Ugalde; Juan Mucci; Diego J Comerci; Rodolfo Augusto Ugalde
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

3.  Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2.

Authors:  Roxana R Ahangarani; Wim Janssens; Vincent Carlier; Luc Vanderelst; Thierry Vandendriessche; Marinee Chuah; Marc Jacquemin; Jean-Marie Saint-Remy
Journal:  Mol Ther       Date:  2010-12-14       Impact factor: 11.454

4.  Recombinant Dirofilaria immitis polyprotein that stimulates murine B cells to produce nonspecific polyclonal immunoglobulin E antibody.

Authors:  Hiroyuki Tezuka; Shinjiro Imai; Riho Muto; Yuko Furuhashi; Koichiro Fujita
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 5.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

6.  The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization.

Authors:  Hui Xu; Lip Nyin Liew; I Chun Kuo; Chiung Hui Huang; Denise Li-Meng Goh; Kaw Yan Chua
Journal:  Immunology       Date:  2008-03-18       Impact factor: 7.397

7.  A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.

Authors:  Fernanda I Staquicini; Anita Tandle; Steven K Libutti; Jessica Sun; Maya Zigler; Menashe Bar-Eli; Fabiana Aliperti; Elizabeth C Pérez; Jeffrey E Gershenwald; Mario Mariano; Renata Pasqualini; Wadih Arap; José Daniel Lopes
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

8.  Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg).

Authors:  Joonyong Noh; Wahn Soo Choi; Geunwoong Noh; Jae Ho Lee
Journal:  Immune Netw       Date:  2010-12-31       Impact factor: 6.303

9.  IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells.

Authors:  Jae Ho Lee; Joonyong Noh; Geunwoong Noh; Wahn Soo Choi; Sang Sun Lee
Journal:  Yonsei Med J       Date:  2011-09       Impact factor: 2.759

Review 10.  Role of IL-10 in the resolution of airway inflammation.

Authors:  Yoshiko Ogawa; Enrico A Duru; Bill T Ameredes
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.